Comparative effects of K+ channel modulating agents on contractions of rat intestinal smooth muscle

M P Davies1, J R McCurrie, D Wood

  • 1Postgraduate Studies in Pharmacology, School of Pharmacy, University of Bradford, West Yorkshire, UK.

Insights

Six K+ channel openers relaxed rat ileum smooth muscle by activating ATP-dependent K+ channels. Glibenclamide blocked these effects, suggesting specific channel involvement in intestinal muscle regulation.

Area of Science:

  • Pharmacology
  • Physiology
  • Gastroenterology

Background:

  • Smooth muscle contraction is regulated by ion channels.
  • Potassium (K+) channels play a crucial role in smooth muscle relaxation.
  • Understanding K+ channel opener mechanisms in the intestine is important for therapeutic development.

Purpose of the Study:

  • To investigate the effects of six K+ channel openers on rat ileum longitudinal muscle-myenteric plexus.
  • To determine the specific K+ channels involved in mediating relaxation in intestinal smooth muscle.
  • To compare the potency and efficacy of different K+ channel openers.

Main Methods:

  • Isolated rat ileum longitudinal muscle-myenteric plexus preparation.
  • Electrical field stimulation and K+-induced contraction assays.
  • Dose-response studies with K+ channel openers and antagonists (glibenclamide, tetraethylammonium, yohimbine).

Main Results:

  • Levcromakalim, pinacidil, RP 49356, and SDZ PCO 400 abolished electrical field stimulation-induced contractions and relaxed K+-induced contractions.
  • Minoxidil sulphate was less potent, and diazoxide was ineffective.
  • Relaxant effects were antagonized by glibenclamide, tetraethylammonium, and yohimbine, indicating involvement of glibenclamide-sensitive ATP-dependent K+ channels.

Conclusions:

  • The relaxant effects of tested K+ channel openers in rat intestinal smooth muscle are mediated by glibenclamide-sensitive ATP-dependent K+ channels.
  • These compounds do not preferentially inhibit direct smooth muscle or nerve-mediated responses.
  • Differences in K+ channels or their regulatory sites may exist between intestinal and vascular smooth muscle.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...